Authors:
Fizazi, K
Tjulandin, S
Salvioni, R
Germa-Lluch, JR
Bouzy, J
Ragan, D
Bokemeyer, C
Gerl, A
Flechon, A
de Bono, JS
Stenning, S
Horwich, A
Pont, J
Albers, P
De Giorgi, U
Bower, M
Bulanov, A
Pizzocaro, G
Aparicio, J
Nichols, CR
Theodore, C
Hartmann, JT
Schmoll, HJ
Kaye, SB
Culine, S
Droz, JP
Mahe, C
Citation: K. Fizazi et al., Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group, J CL ONCOL, 19(10), 2001, pp. 2647-2657
Authors:
de Bono, JS
Dalgleish, AG
Carmichael, J
Diffley, J
Lofts, FJ
Fyffe, D
Ellard, S
Gordon, RJ
Brindley, CJ
Evans, TRJ
Citation: Js. De Bono et al., Phase I study of ONO-4007, a synthetic analogue of the lipid a moiety of bacterial lipopolysaccharide, CLIN CANC R, 6(2), 2000, pp. 397-405
Authors:
de Bono, JS
Paul, J
Simpson, A
Anthoney, A
Kirk, D
Underwood, M
Graham, J
Kaye, SB
Citation: Js. De Bono et al., Improving the outcome of salvage treatment for nonseminomatous germ cell tumours (NSGCT), BR J CANC, 83(4), 2000, pp. 426-430
Authors:
Jarmin, DI
Nibbs, RJB
Jamieson, T
de Bono, JS
Graham, GJ
Citation: Di. Jarmin et al., Granulocyte macrophage colony-stimulating factor and interleukin-3 regulate chemokine and chemokine receptor expression in bone marrow macrophages, EXP HEMATOL, 27(12), 1999, pp. 1735-1745